Related Experiment Video
Updated: Feb 26, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.3K
Comparative analyses for plant virus-based cancer immunotherapy drug development.
Anthony O Omole1,2,3,4, Hannah S Newton5, Edward Cedrone5
1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California, San Diego, La Jolla, San Diego, CA 92093, USA.
Cell Biomaterials
|February 25, 2026
Summary
Cowpea mosaic virus (CPMV) effectively reprograms the tumor microenvironment for durable anti-tumor immunity. CPMV, unlike CCMV, strongly induces interferons via Toll-like receptor 7 activation, enhancing immune cell function for cancer immunotherapy.
Area of Science:
- * Virology
- * Immunology
- * Cancer Research
Background:
- * Cowpea mosaic virus (CPMV) exhibits significant anti-tumor properties.
- * Intratumoral administration of CPMV, but not CCMV, enhances systemic anti-tumor immunity.
- * Understanding the mechanism of action is crucial for optimizing viral immunotherapies.
Purpose of the Study:
- * To compare the mechanisms of action between CPMV and CCMV in reprogramming the tumor microenvironment.
- * To elucidate the specific immune responses induced by each virus.
- * To identify the molecular determinants of CPMV's superior immunotherapeutic efficacy.
Main Methods:
- * Side-by-side comparison of CPMV and CCMV.
- * Immune-multiplexing assays to analyze cytokine profiles.
- * Cellular trafficking studies to track viral uptake and processing.
- * Toll-like receptor (TLR) activation assays.
Main Results:
- * CPMV and CCMV show similar uptake rates by innate immune cells but distinct processing pathways.
- * CPMV strongly induces type I, II, and III interferons, enhancing immune cell function.
- * CCMV induces pro-inflammatory interleukins (IL-22, IL-23, IL-27).
- * CPMV RNAs activate TLR7 and exhibit longer intracellular persistence compared to CCMV RNAs.
Conclusions:
- * CPMV's potent immunotherapeutic effect is attributed to its ability to induce robust interferon responses via TLR7 activation.
- * Differential RNA processing and persistence contribute to CPMV's unique mechanism.
- * This study highlights the potential of plant viruses like CPMV as novel agents for cancer immunotherapy and biomedical applications.
Related Concept Videos
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
01:51Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K